Vidéos

Report to Society - Aftermovie of the presentation of the Report at the General Assembly of pharma.be on December 13 2023

Report to Society 2023

Report to Society 2023 - Highlights hospitalisation costs

L'importance des partenariats public-privé dans la R&D

From patient to partner

pharma.be achievements 2023

Caroline Ven, CEO pharma.be - Renforcer la voix des patients

Caroline Ven, CEO pharma.be - L'importance du secteur pharmaceutique pour la Belgique

Caroline Ven, CEO pharma.be - L'importance d'un dialogue entre industrie et pouvoirs publiquess

Koen Raeymaekers, Amgen - Guidelines to improve the collaboration between industry and patient associations

Hans Vandenberghe, Bayer - The Q&A document in the Code of Deontology

Charlotte Weyne - Intellectual Property Rights

Turning ideas into assets in life sciences - 27.09.2023

Welcome to Belgium - pharma.be: the centre of expertise

Belgian economy

Employment

Employment

Short presentation Report to Society 2022